Ca – Case Studies Yield Insight
Total Page:16
File Type:pdf, Size:1020Kb
Open Access: Case Studies For Societies & Journal Publishing with Deni Auclair, Vice President & Lead Analyst, Outsell Inc.; Esmeralda Galán Buchanan, Journals Director, American Cancer Society; Rachel Burley, Vice President & Director of Open Access, John Wiley & Sons; Philip Wright, Chief Executive, The Physiological Society Recorded October 21, 2014 For podcast release, November 19, 2014 KENNEALLY: Good day, everyone. We’re very happy to welcome you to our program today. As you can see from the list of senior executives that we have gathered for this particular Webinar, we’ve got a very rich program, a lot to cover. And really, why are we doing this is always a good question to start with. And we understand at the Copyright Clearance Center that open access is helping mission-driven publishing societies to disseminate knowledge, which is their primary goal, but it’s also causing them to reevaluate their financial business models. And so we thought by working together with our partners on this program at Wiley, that we would give you all an opportunity to hear from your colleagues and get to understand better some case studies from our panel of experts. And they’re going to share insights on the challenges and solutions that they have put in place for open access and perhaps provide you with some keys and some clues for your own strategies to implement open access journals. And so we look forward to having you with us for the next hour or so. So we’ll take 45 minutes, because we’re going to give you some time for questions, as Casey Bassett said. We will ask you to use the chat box in the lower right corner of your screen to let us know what’s on your mind, if you have an immediate clarification that you need to be made or if you have a question. In particular, if you have a question for one of our panelists, please try to indicate if it’s for one or the other, and we’ll make sure to direct it to them. So what are we going to get to today? We’re going to understand just how we got to 2014 and look ahead. We will take, as I say, a careful study of several particular society publishers and how they have approached this issue. We’re going to hear from Philip Wright at the Physiological Society, as well as Esmerelda Buchanan at the American Cancer Society. And we’ll also give you some of our own commentary and review from colleagues here at Copyright Clearance Center and at Wiley. And, as I say, we will take your questions. We are tweeting. We used a hashtag for this particular program, #OAandSOC, so that’s #OAandSOC. You see that in the lower left hand corner of your screen. And Copyright Clearance center is on Twitter @copyrightclear. And we’ll give you Twitter handles for all of the panelists as we get to them. And it’s important, I think, to acknowledge that we are speaking to you today as part of Open Access Week, a global event that is now entering its eighth year, an opportunity for the academic and research and publishing communities to continue to learn about open access and share what they’ve learned with their colleagues. Just a quick check on Twitter this morning shows me that this is indeed a global event. As we know, we have participants on our Webinar today from across Europe, North America and even in Asia, so we’re very much a part of that global effort. It’s a really terrific chance, Open Access Week, to connect and understand all the various policy changes, to bring together universities, colleges, research institutes, funding agencies, libraries, as well as publishers and authors, indeed, to discuss all of these issues. And one interesting thing to say, we have been chatting about Copyright Clear – sorry, we’ve been chatting about open access here at Copyright Clearance Center, through these Webinars, with you for nearly two years now, and you would think that we’ve said all that there is need to be said. But in fact, a recent survey just published this week as part of open access, by the Nature Publishing Group and Palgrave Macmillan, gives us an idea of just the continuing need for information. They surveyed something like 30,000 authors about open access, and they found that one in five science authors, and roughly one in 10 of the humanities and social sciences, do not know if their main funder requires them to publish open access. And a significant number of authors are also unaware of the requirements of even the largest OA funders with long established mandates. So a report, a survey that I think everybody on this call will want to have a look at. You can find that online and perhaps on Twitter as well, as part of the Open Access Week celebrations, and we can call them that. I’d like to turn right now to our first presenter, Deni Auclair. Deni, welcome to the program. AUCLAIR: Thank you. KENNEALLY: Deni Auclair, we’ll tell people about your background. Deni Auclair joined Outsell Incorporated, the only research and advisory firm focused on the information industry, in November of 2013, as vice president and lead analyst, covering science, technology, medical and healthcare. Before joining Outsell, Deni Auclair was president of Media Growth Strategies, and she was previously vice president, corporate development, at John Wiley and Sons and served as CFO at the Journal of Bone and Joint Surgery. And she is on Twitter @outsellinc. And so Deni Auclair, again, welcome to the program. And what I think is important for our audience to understand, and we just heard it in your background, is that you simply haven’t been watching this from the outside. You have been part of this. And so you have some perspective that I think is important to share. And what I’d like to do very quickly is to look backward and look ahead with you. Open access isn’t new, necessarily, but it certainly has been dominating the headlines in the STM publishing community and indeed in academia for some time. Can you give us a quick retrospective on how we got to where we are today? AUCLAIR: Sure. Well, one of the most interesting things I heard recently was at the SSP meeting in Boston, when a person from the OSTP, from the President’s office, said that the minute President Obama came into office, he said that he was going to make sure that research would be opened. And from that point on, it has had a snowball effect, and we’ve seen the growth of open access, albeit not meteoric, but certainly the conversations have been expanding rapidly. But the growth of open access has not been as fast as the advocates would like it to be, but we’ve definitely seen the growth of an acceptance, by the commercial publishing sector, of open access. I remember very well when there was just vigorous lobbying against open access by the commercial publishers, the big guys, and the resistance on the other side from the open access advocates. And I just remember the ripple, the waves that went through the industry when it really became known that it was going to happen. And it has. So it – yeah? KENNEALLY: Yeah, well, indeed, I was going to say that in a sense we’ve been thinking about this as revolution, but indeed it has turned out to be an evolution in the publishing world. AUCLAIR: Exactly, exactly. It has turned into what – it’s been a discussion around what are the business models that are going to work, how is everybody going to come out satisfied and happy. In other words, how are publishers going to maintain their margins through what business models? And the business models have continued to proliferate. We have very interesting range of from green to gold to – hybrid is not really a model, but it is when you’re looking at the journal level as opposed to the article level. There’s also the growth of society’s gold-for-gold model. There’s PRJ’s membership model. There’s just all these different models and people testing the waters to see what’s going to work. And we’re stilling working on that. And I think what’s been interesting is how there’s been a convergence, where now everybody’s on the same page to try to make this work so that everybody can come out where they want to be in the next 10 to 20 years. KENNEALLY: Indeed, I’m thinking about another evolution, and I believe the quote was, let a thousand flowers bloom. And in this case here, with open access, we are at least seeing dozens of business models. Just a couple of weeks ago at the Frankfurt Book Fair, I had an opportunity to host a town meeting discussion about open access, and who holds the power was the question that we put to our panelists and a variety of people from around the STM publishing world, indeed from around the world. And one of the things I was reminded of was that when we go all the way back to the very beginning of the last decade, with the launch of BioMed Central, there was really no business model. So it shouldn’t surprise us that it has taken this amount of time to get where we are with a proliferation of those models.